INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $47,965,983 |
| Submission deadline | Deadline not published |
| Published | Sep 25, 2020 |
| Buyer | Office of Assistant Secretary for Preparedness and Response |
| Country | United States · OH |
| CPV code | NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTEC) · PSC AZ13 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $47,965,983
- Submission deadline
- Deadline not published
- Published
- Sep 25, 2020
- Country
- United States
- CPV code
- NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTEC) · PSC AZ13
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| INVIRSA, INC. | US-UEI: SN3VBD5EQMK6 | United States | $47,965,983 | Sep 25, 2020 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.
Awarding Agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response.
NAICS 541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY).
PSC AZ13: R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT).
Period of Performance: 2020-09-28 to 2030-09-04.